Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Translate Bio, Inc. (TBIO) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Translate Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1693415.
Total stock buying since 2018: $2,753,701,666.
Total stock sales since 2018: $269,291,437.
Total stock option exercises since 2018: $527,952.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 71,983,597 | $2,735,376,686 | 3,110,809 | $118,210,742 | 14,665 | $111,052 |
| 2020 | 500,000 | $11,000,000 | 7,306,934 | $151,080,695 | 53,007 | $416,900 |
| 2018 | 563,460 | $7,324,980 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-09 | 71,983,597 | $2,735,376,686 | 3,110,809 | $118,210,742 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 9,026 | $66,702 |
| 2021-01 | 0 | $0 | 0 | $0 | 5,639 | $44,350 |
| 2020-12 | 0 | $0 | 139,101 | $3,544,220 | 0 | $0 |
| 2020-11 | 0 | $0 | 0 | $0 | 53,007 | $416,900 |
| 2020-08 | 0 | $0 | 88,888 | $1,318,115 | 0 | $0 |
| 2020-06 | 500,000 | $11,000,000 | 7,078,945 | $146,218,360 | 0 | $0 |
| 2018-07 | 563,460 | $7,324,980 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-14 | Burgess Paul D. (Chief Operating Officer, CLO) | Sale | 71,833 | 38.00 | 2,729,654 |
| 2021-09-14 | Hughes Owen (Director) | Sale | 29,860 | 38.00 | 1,134,680 |
| 2021-09-14 | Renaud Ronald C Jr (Chief Executive Officer) | Sale | 954,053 | 38.00 | 36,254,014 |
| 2021-09-14 | Sanofi (10% Owner) | Buy | 71,983,597 | 38.00 | 2,735,376,686 |
| 2021-09-14 | Formela Jean Francois (Director) | Sale | 2,055,063 | 38.00 | 78,092,394 |
| 2021-04-07 | Renaud Ronald C Jr (Chief Executive Officer) | Option Ex | 9,026 | 7.39 | 66,702 |
| 2021-01-14 | Renaud Ronald C Jr (Chief Executive Officer, Pres.) | Option Ex | 5,639 | 7.87 | 44,350 |
| 2020-12-22 | Formela Jean Francois | Sale | 82,565 | 25.46 | 2,102,270 |
| 2020-12-21 | Formela Jean Francois | Sale | 56,536 | 25.50 | 1,441,950 |
| 2020-11-16 | Renaud Ronald C Jr (Chief Executive Officer, Pres.) | Option Ex | 53,007 | 7.87 | 416,900 |
| 2020-08-27 | Formela Jean Francois (Director) | Sale | 10,097 | 14.38 | 145,215 |
| 2020-08-26 | Formela Jean Francois (Director) | Sale | 44,381 | 14.80 | 656,750 |
| 2020-08-25 | Formela Jean Francois (Director) | Sale | 34,410 | 15.00 | 516,150 |
| 2020-06-30 | Takeda Pharmaceutical Co Ltd | Sale | 6,824,992 | 20.68 | 141,140,834 |
| 2020-06-26 | Klarman Seth A | Buy | 500,000 | 22.00 | 11,000,000 |
| 2020-06-03 | Takeda Pharmaceutical Co Ltd | Sale | 40,086 | 19.75 | 791,698 |
| 2020-06-02 | Takeda Pharmaceutical Co Ltd | Sale | 105,395 | 19.89 | 2,095,779 |
| 2020-06-01 | Takeda Pharmaceutical Co Ltd | Sale | 108,472 | 20.19 | 2,190,049 |
| 2018-07-02 | Mrl Ventures Fund Llc (10% Owner) | Buy | 25,000 | 13.00 | 325,000 |
| 2018-07-02 | Gallagher Brian M. Jr. (Director) | Buy | 269,230 | 13.00 | 3,499,990 |
| 2018-07-02 | Glaxosmithkline Plc | Buy | 269,230 | 13.00 | 3,499,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of TBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Translate Bio, Inc. (symbol TBIO, CIK number 1693415) see the Securities and Exchange Commission (SEC) website.